Walleye Capital
NMTC icon

Walleye Capital’s NeuroOne Medical Technologies NMTC Stock Holding History

Walleye Capital’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,659
Closed -$201K – 5330
2023
Q3 		$201K Buy
+37,659
New +$252K ﹤0.01% 3552

Other funds holding NMTC

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WAAG
Wealth Alliance Advisory Group Wichita, Kansas $691M AUM 24.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Walleye Capital's NMTC Position: Q4 2023 in Review

Walleye Capital sold out of NeuroOne Medical Technologies (NMTC) in Q4 2023, closing a stake of 37,659 shares — an estimated $201K sold.

Walleye Capital first reported a position in NMTC in Q3 2023 and held it in 1 quarter. The position peaked at $201K in Q3 2023. 20 funds tracked by Wall St. Rank hold NMTC as of Q4 2023.

  • Walleye Capital reported no remaining NeuroOne Medical Technologies position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 37,659 NeuroOne Medical Technologies shares in Q4 2023, an estimated $201K.
  • Walleye Capital first reported a position in NeuroOne Medical Technologies in Q3 2023 and held it in 1 quarter.
  • Walleye Capital's NeuroOne Medical Technologies position peaked at $201K in Q3 2023.
  • 20 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.